Bruker and iTomography Corporation Announce License Agreement for iTomo Image Reconstruction Software
Bruker and iTomography Corporation today announced they have entered into a multi-year license agreement for the patented technology invented by Dr. Alexander Katsevich, iTomography’s Chief Technology Officer and a professor at the University of Central Florida. This will give Bruker non-exclusive rights to the software for performing CT imaging using the theoretically exact image reconstruction algorithm iTomo®.
In the near-term, exact helical reconstruction will be available on number of SkyScan™ instruments produced by Bruker microCT. Dr. Michael Frenkel, CEO of iTomography, stated: “Bruker is a leading worldwide provider of microCT imaging systems, and we are proud to have iTomography’s disruptive CT technologies utilized by Bruker’s customers worldwide for biomedical, pre-clinical, material science, geological, and other applications. iTomography believes that practical utilization of licensed technologies will improve the quality of imaging and expand the spectrum of applications of microtomography and nanotomography scanners.”
Dr. Alexander Sasov, CEO of Bruker microCT, stated: “Our goal is to provide researchers with the best imaging instruments. Using licensed exact helical reconstruction algorithms allow significant improvement in 3D metrological accuracy of results and offer various enhancements in application areas to satisfy the needs of our customers”.
This article has been republished from materials provided by Bruker. Note: material may have been edited for length and content. For further information, please contact the cited source.
Simple Water Test Could Prevent Crippling Bone DiseaseNews
A simple colour-changing test to detect fluoride in drinking water, could in the future prevent the crippling bone disease, skeletal fluorosis, in developing countries such as India and Tanzania.READ MORE
Allergy Amplifier Implicated in Asthma Also Intensifies Food AllergyNews
Scientist who previously reported that a small protein, aptly named histamine-releasing factor, played a pro-inflammatory role in asthma have now shown that it also serves as a “food allergy amplifier”. This work paves the way for blood tests to predict which patients will respond to allergy therapy, and strongly supports the idea that drugs designed to block HRF could prevent food allergy attacks.READ MORE
Higher Diabetes Rates in Minorities May be Driven By Environmental PollutantsNews
Unequal exposure to environmental pollutants acting as endocrine-disrupting chemicals is an under-recognized risk factor that may play a key role in driving the higher rates of diabetes among minority and low-income populations.READ MORE